SelectQuote Inc. Reports Q4 FY2025 Revenue of $345.1M, Up from $307.2M; Swings to $12.9M Net Income from $31.0M Loss; Adjusted EBITDA Falls to $2.7M from $14.4M

Reuters
2025/08/21
SelectQuote Inc. Reports Q4 FY2025 Revenue of $345.1M, Up from $307.2M; Swings to $12.9M Net Income from $31.0M Loss; Adjusted EBITDA Falls to $2.7M from $14.4M

SelectQuote, Inc. (NYSE: SLQT) has released its financial results for the fourth quarter of fiscal year 2025. The company reported consolidated revenue of $345.1 million, an increase from $307.2 million in the same quarter of the previous year. Net income for the quarter was $12.9 million, a notable improvement compared to a net loss of $31.0 million in the fourth quarter of fiscal year 2024. Adjusted EBITDA for the quarter was $2.7 million, down from $14.4 million in the prior year quarter. For fiscal year 2026, SelectQuote has provided guidance, expecting revenue to range between $1.650 billion and $1.750 billion. The company also anticipates Adjusted EBITDA to be in the range of $120 million to $150 million. Breaking down the segment results for the fourth quarter of fiscal year 2025, the Senior segment reported revenue of $82.5 million with an Adjusted EBITDA of $7.7 million. The Healthcare Services segment generated $214.0 million in revenue and an Adjusted EBITDA of $11.9 million. The Life segment had revenue of $48.0 million and an Adjusted EBITDA of $6.9 million. SelectQuote continues to emphasize the strength of its holistic healthcare services model, attributing its performance to the talent and hard work of its leadership and workforce.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SelectQuote Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250821115007) on August 21, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10